Infinity Pharmaceuticals (INFI)

Infinity Pharma (INFI) Stock Price & Analysis


INFI Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $1.30
Previous Close$0.01
Average Volume (3M)3.94M
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$17.70M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)>-0.1
Nov 01, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding90,761,081
10 Day Avg. Volume1,964,965
30 Day Avg. Volume3,937,684
Standard Deviation0.34
Financial Highlights & Ratios
Price to Book (P/B)-0.04
Price to Sales (P/S)1.95
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Infinity Pharmaceuticals’s price range in the past 12 months?
Infinity Pharmaceuticals lowest stock price was $0.01 and its highest was $1.30 in the past 12 months.
    What is Infinity Pharmaceuticals’s market cap?
    Currently, no data Available
    When is Infinity Pharmaceuticals’s upcoming earnings report date?
    Infinity Pharmaceuticals’s upcoming earnings report date is Nov 01, 2023 which is in 33 days.
      How were Infinity Pharmaceuticals’s earnings last quarter?
      Infinity Pharmaceuticals released its earnings results on Aug 08, 2023. The company reported -$0.111 earnings per share for the quarter, beating the consensus estimate of -$0.12 by $0.009.
        Is Infinity Pharmaceuticals overvalued?
        According to Wall Street analysts Infinity Pharmaceuticals’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Infinity Pharmaceuticals pay dividends?
          Infinity Pharmaceuticals does not currently pay dividends.
          What is Infinity Pharmaceuticals’s EPS estimate?
          Infinity Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Infinity Pharmaceuticals have?
          Infinity Pharmaceuticals has 90,761,080 shares outstanding.
            What happened to Infinity Pharmaceuticals’s price movement after its last earnings report?
            Infinity Pharmaceuticals reported an EPS of -$0.111 in its last earnings report, beating expectations of -$0.12. Following the earnings report the stock price went up 44.444%.
              Which hedge fund is a major shareholder of Infinity Pharmaceuticals?
              Among the largest hedge funds holding Infinity Pharmaceuticals’s share is Carlson Capital LP. It holds Infinity Pharmaceuticals’s shares valued at 273K.


                Infinity Pharma Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Infinity Pharmaceuticals

                Infinity Pharmaceuticals, Inc. operates as a biopharmaceutical company, which engages in discovering, developing and delivering medicines for people with cancer. It focuses on drug development. The company was founded by Steven H. Holtzman on March 22, 1995 and is headquartered in Cambridge, MA.


                Top 5 ETFs holding INFI

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold INFI. The ETFs are listed according to market value of INFI within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Cellectar Biosciences
                Daré Bioscience
                Eloxx Pharmaceuticals

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis